Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Retained Earnings (2016 - 2025)

Historic Retained Earnings for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$87.7 million.

  • CV Sciences' Retained Earnings fell 166.05% to -$87.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.7 million, marking a year-over-year decrease of 166.05%. This contributed to the annual value of -$87.0 million for FY2024, which is 283.02% down from last year.
  • As of Q3 2025, CV Sciences' Retained Earnings stood at -$87.7 million, which was down 166.05% from -$87.4 million recorded in Q2 2025.
  • CV Sciences' Retained Earnings' 5-year high stood at -$67.0 million during Q1 2021, with a 5-year trough of -$87.7 million in Q3 2025.
  • Over the past 5 years, CV Sciences' median Retained Earnings value was -$84.6 million (recorded in 2023), while the average stood at -$82.5 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 4329.86% in 2021, then skyrocketed by 353.75% in 2023.
  • CV Sciences' Retained Earnings (Quarter) stood at -$79.5 million in 2021, then decreased by 10.34% to -$87.7 million in 2022, then rose by 3.54% to -$84.6 million in 2023, then decreased by 2.83% to -$87.0 million in 2024, then fell by 0.86% to -$87.7 million in 2025.
  • Its last three reported values are -$87.7 million in Q3 2025, -$87.4 million for Q2 2025, and -$87.1 million during Q1 2025.